« Back
Home /
Cangrelor free acid

Cangrelor free acid

Item no.	DCC-DC7005-250mg
Manufacturer	DCChemicals
CASRN	163706-06-7
Amount	250 mg
Quantity options	100 mg 10 mM x 1 ml in DMSO 1 g 250 mg
Category	Reagents & Chemicals Molecules
Type	Inhibitors
Specific against	other
Purity	>98%
Smiles	CSCCNC1=NC(=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O)SCCC(F)(F)F
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Cangrelor,ARC69931,ARC 69931
Similar products	163706-06-7
Available
Manufacturer - Applications	Cangrelor is a P2Y12 inhibitor, and was approved in June 2015 as an antiplatelet drug for intravenous application. Cangrelor is a high-affinity, reversible inhibitor of P2Y12 receptors that causes almost complete inhibition of ADP-induced platelet aggrega
Storage Conditions	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Molecular Weight	776, 362
Note	For research only, not for human use.
Chemical name	tetrasodium; [dichloro(phosphonato)methyl]-[[(2R, 3S, 4R, 5R)-3, 4-dihydroxy-5-[6-(2-methylsulfanylethylamino)-2-(3, 3, 3-trifluoropropylsulfanyl)purin-9-yl]oxolan-2-yl]methoxy-oxidophosphoryl]oxyphosphinate

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 250 mg

available

Delivery expected until 9/25/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer